The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: March 2025

October 17, 2025
Highlights in Cancer Research: November 2022

Related articles

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.


6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation

  • 1. Immune evasion through mitochondrial transfer in the tumour microenvironment
  • 2. Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
  • 3. Controlling intracellular protein delivery, tumor colonization and tissue distribution using flhDC in clinically relevant ΔsseJ Salmonella
  • 4. Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
  • 5. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
  • 6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation
  • 7. Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer
  • 8. Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening
  • 9. Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment
  • 10. Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Previous
Next

Canato, S. et al. Cancer Discovery. 15(2): 427–443. (2025).
doi: 10.1158/2159-8290.CD-24-0263.

Summary of the findings

Basal cell carcinoma (BCC) is the most frequent cancer in humans. Stem cells (SCs) but not progenitors are competent to initiate BCC formation following oncogenic hedgehog signaling activation. However, the mechanisms conferring the competence to BCC formation in SCs and restricting tumour formation in progenitors were not known. This study uncovered the mechanisms allowing SCs and not progenitors to initiate BCC formation.
.
Canato and colleagues uncovered that Survivin, a protein regulating proliferation and apoptosis, is expressed at a higher level in SCs compared to progenitors. Using genetic gain and loss of function of Survivin in mouse models, the authors showed that Survivin deletion in oncogene-expressing SCs prevents BCC formation, whereas Survivin overexpression renders oncogene-expressing progenitors competent to BCC formation. Survivin expression enhances cell survival and renewing divisions, while restricting apoptosis and differentiation. The authors showed that pharmacological inhibition of Survivin or of SGK1, a downstream factor regulated by Survivin, prevents the conversion of preneoplastic lesions into invasive BCCs.
.

Altogether, this study identifies Survivin as a key licensing factor expressed by SCs that regulate BCC formation by promoting self-renewal and survival, while preventing cell death and differentiation in oncogene-expressing cells. In addition, the demonstration that Survivin expression is required for BCC formation suggests that Survivin or SGK1 inhibitors can be used to prevent the progression of preneoplastic lesions into invasive skin cancer.

.
Read more in Cancer Discovery

6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation

  • 1. Immune evasion through mitochondrial transfer in the tumour microenvironment
  • 2. Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
  • 3. Controlling intracellular protein delivery, tumor colonization and tissue distribution using flhDC in clinically relevant ΔsseJ Salmonella
  • 4. Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
  • 5. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
  • 6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation
  • 7. Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer
  • 8. Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening
  • 9. Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment
  • 10. Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026

Erik Sahai, Principal Group Leader and Deputy Research Director at the Francis Crick Institute, travelled to Nanchang, China, this month to deliver an EACR keynote talk...

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

August 17, 2026

Nazha Ghaleb (who goes by Nana) has been an EACR member for over two years, and an EACR Ambassador for much of that time. A molecular...

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

August 12, 2026

EACR member Amel Aziba has now completed her EACR-Molecular Oncology Editorial Fellowship, funding that is awarded to enable a talented cancer researcher to gain knowledge and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Spotlight on the Portuguese Association for Cancer Research (ASPIC)
Community

Spotlight on the Portuguese Association for Cancer Research (ASPIC)

August 27, 2026
EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference
Community

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR